New Israeli Funds Supporting Neuroscience Startups And R&D

An Israeli investment firm is helping researchers and entrepreneurs develop innovative solutions for mental health and neurodegenerative disorders. 

Corundum Neuroscience, formerly known as Joy Ventures, has launched both a fund to spur neuroscience research and innovation and a venture builder to help entrepreneurs start and grow their companies. 

It will support the entire innovation process, from the earliest stages of research through commercialization to encourage the success of its portfolio companies. 

Corundum’s team of researchers, academics and business leaders will provide guidance to these startups and entrepreneurs as they develop their neuroscience-driven solutions.

The investment firm rebranded itself from Joy Ventures to signify its greater focus on furthering neuroscience research and innovation. 

Corundum Neuroscience’s portfolio of companies includes NYX Technologies, developer of a wearable headset to enhance sleep, Myndlift, provider of custom brain-training plans to improve mental health, and more.

“Corundum Neuroscience bridges the gap between early-stage research and market launch for innovation in the neuroscience technology domain,” said Liron Nunez Weissman, CEO of Corundum Neuroscience.

“We understand the challenges innovators in this space contend with, and our long-term funding approach provides the flexibility necessary to bring to market solutions that will improve people’s health, longevity and happiness.”